Suppr超能文献

Editorial: Pathogenesis, vaccines, and antivirals against respiratory viruses.

作者信息

Caceres C Joaquin, Susta Leonardo, Rajao Daniela S

机构信息

Department of Population Health, College of Veterinary Medicine, University of Georgia, Athens, GA, United States.

Department of Pathobiology, Ontario Veterinary College, University of Guelph, Ontario, ON, Canada.

出版信息

Front Cell Infect Microbiol. 2023 May 8;13:1202251. doi: 10.3389/fcimb.2023.1202251. eCollection 2023.

Abstract
摘要

相似文献

1
Editorial: Pathogenesis, vaccines, and antivirals against respiratory viruses.
Front Cell Infect Microbiol. 2023 May 8;13:1202251. doi: 10.3389/fcimb.2023.1202251. eCollection 2023.
2
Antiviral chemotherapeutic agents against respiratory viruses: where are we now and what's in the pipeline?
Curr Opin Pulm Med. 2004 May;10(3):197-203. doi: 10.1097/00063198-200405000-00009.
3
5
Addressing the Threat of Emerging Viral Infections.
Keio J Med. 2023;72(1):27. doi: 10.2302/kjm.ABSTRACT_72_1-2.
6
Antiviral role of toll-like receptor-3 agonists against seasonal and avian influenza viruses.
Curr Pharm Des. 2009;15(11):1269-74. doi: 10.2174/138161209787846775.
7
Animal models for studying coronavirus infections and developing antiviral agents and vaccines.
Antiviral Res. 2022 Jul;203:105345. doi: 10.1016/j.antiviral.2022.105345. Epub 2022 May 21.
8
Virucidal activity of a scorpion venom peptide variant mucroporin-M1 against measles, SARS-CoV and influenza H5N1 viruses.
Peptides. 2011 Jul;32(7):1518-25. doi: 10.1016/j.peptides.2011.05.015. Epub 2011 May 19.
9
Ultra-long-acting antivirals as chemical vaccines to prevent viral diseases.
Future Microbiol. 2022 Jul;17:887-897. doi: 10.2217/fmb-2021-0254. Epub 2022 Jun 6.
10
Human Defensins from Antivirals to Vaccine Adjuvants: Rediscovery of the Innate Immunity Arsenal.
Protein Pept Lett. 2022;29(2):121-124. doi: 10.2174/0929866528666211125110058.

本文引用的文献

1
Population-based hospitalization burden estimates for respiratory viruses, 2015-2019.
Influenza Other Respir Viruses. 2022 Nov;16(6):1133-1140. doi: 10.1111/irv.13040. Epub 2022 Aug 22.
3
Influenza antivirals and animal models.
FEBS Open Bio. 2022 Jun;12(6):1142-1165. doi: 10.1002/2211-5463.13416. Epub 2022 Apr 27.
4
Sex Differences in Respiratory Viral Pathogenesis and Treatments.
Annu Rev Virol. 2021 Sep 29;8(1):393-414. doi: 10.1146/annurev-virology-091919-092720. Epub 2021 Jun 3.
5
Viral Respiratory Pathogens and Lung Injury.
Clin Microbiol Rev. 2021 Mar 31;34(3). doi: 10.1128/CMR.00103-20. Print 2021 Jun 16.
6
Respiratory viral infections in the elderly.
Ther Adv Respir Dis. 2021 Jan-Dec;15:1753466621995050. doi: 10.1177/1753466621995050.
7
Vaccines and Therapeutics Against Hantaviruses.
Front Microbiol. 2020 Jan 30;10:2989. doi: 10.3389/fmicb.2019.02989. eCollection 2019.
8
Universal Vaccines and Vaccine Platforms to Protect against Influenza Viruses in Humans and Agriculture.
Front Microbiol. 2018 Feb 6;9:123. doi: 10.3389/fmicb.2018.00123. eCollection 2018.
9
Vaccination strategies against respiratory syncytial virus.
Proc Natl Acad Sci U S A. 2016 Nov 15;113(46):13239-13244. doi: 10.1073/pnas.1522597113. Epub 2016 Oct 31.
10
Association of Single-Nucleotide Polymorphisms in IL28B, but Not TNF-α, With Severity of Disease Caused by Andes Virus.
Clin Infect Dis. 2015 Dec 15;61(12):e62-9. doi: 10.1093/cid/civ830. Epub 2015 Sep 22.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验